Dr. Surbhi Sidana is an Assistant Professor of Medicine at Stanford University and specializes in the treatment of multiple myeloma and related disorders. Dr Sidana leads the myeloma CAR-T/immunotherapy program at Stanford and the myeloma disease focused group in the BMT and Cell Therapy Division. She has an active clinical research portfolio and leads clinical trials, especially those focusing on CAR-T cell therapy, immunotherapies such as bispecific antibodies and transplantation in myeloma. Prior to joining Stanford University, Dr Sidana completed her Hematology/Oncology fellowship and additional training in plasma cell disorders at Mayo Clinic, Rochester, MN.
Dr Sidana has published over 80 manuscripts. She is an active member of the International Myeloma Working Group and Co-chairs the Quality-of-Life Committee. She is also the Vice-Chair of the American Society of Hematology Committee on Communications.
